Molecular Events and Mechanisms of Apoptosis

Sepsis

Volumn 2, Issue 1, 1998, Pages 9-19

  Carmody, Ruaidhri J ^a   Cotter, Thomas G ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002043234     PISSN: 13850229     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009742830264     Document Type: Article

References (121)

1. Kerr JFR, Wyllie AH, Currie AH. Apoptosis, a basic biological phenomenon with wider implications in tissue kinetics. Br J Cancer 1972;26:239-245.
2. Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980;68:251-306.
3. Trump BF, Berezesky IK, Osornio-Vargas AR. Cell death and disease process. The role of calcium. In: Cell death in biology and pathology. Bowen ID, Lockshin RA, eds. New York: Chapman and Hall, 1989:1-25.
4. Trump BF, Berezesky IK, Osornio-Vargas AR. Cell death and disease process. Cell Death in Biology and Pathology. Bowen ID, Lockshin RA, eds. New York: Chapman and Hall, 1981:209-242.
5. Cohen JJ, Duke RC. Glucocorticoid activation of a calcium-dependant endonuclease in thymocyte nuclei leads to cell death. J Immunol 1984;132:38-42.
6. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M. Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 1993;12:3670-3684.
7. Brown DG, Sun XM, Cohen GM. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J Biol Chem 1993;268: 3037-3039.
8. Walker PR, Pandey S, Sikorska M. Degradation of chromatin in apoptotic cells. Cell Death Differ 1995;2:97-104.
9. Filipski J, Leblanc J, Youdale T, Sikorska M, Walker PR. EMBO J 1990;9:1319-1327.
10. Walker PR, Sikorska M. Modulation of the sensitivity of chromatin to exogenous nucleases: Implications for the apparent increased sensitivity of transcriptionally active genes. Biochemistry 1986;25:3839-3845.
11. Barry MA, Eastman A. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Arc Biochem Biophys 1993;300:440-450.
12. Hughes FM, Cidlowski JA. Apoptotic DNA degradation: Evidence for novel enzymes. Cell Death Differ 1994;1: 11-17.
13. Fernandes RS, Cotter TG. Activation of a calcium and magnesium independent endonuclease in human leukemic cell apoptosis. Anticancer Res 1993;13:1253-1260.
14. Martin SJ, O'Brien GA, Nishioka WK, McGahon AJ, Mahboubi A, Saido TC, Green DR. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem 1995;270:6425-6428.
15. Cotter TG, Lennon SV, Glynn JM, Green DR. Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumour cells undergoing apoptosis. Cancer Res 1992; 52:997-1005.
16. Martin SJ, Cotter TG. Disruption of micro tubules induces an endogenous suicide pathway in human leukemia HL60 cells. Cell Tiss Kinet 1991;23:545-559.
17. Fesus L, Thomazy V, Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 1987;224:104-108.
18. Savill JS, Henson PM, Haslett C. Phagocytosis of aged human neutrophils by a novel charge sensitive recognition mechanism. J Clin Invest 1989;90:1518-1527.
19. Fadok VA, Lazslo DJ, Noble PW, Weinstein L, Riches DWH, Henson PM. Particle digestibility is required for induction of phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells. J Immunol 1993;151:4274-4285.
20. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognise and remove apoptotic cells. J Immunol 1992;149:4029-4035.
21. Martin SJ, Reutlingsperger CP, McGahon AJ, Rader AJ, van-Schie RC, LaFace DM, Green DR. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182:1545-1556.
22. Nicotera P, Zhirotovsky B, Bellamo G, Orrenius S. Ion signalling in apoptosis. In: Apoptosis. Schimke RT, Mihich E, eds. New York: Plenum Press, 1994:97-126.
23. McConkey DJ, Nicoterra P, Orrenius S. Signalling and chromatin fragmentation in thymocyte apoptosis. Immunol Rev 1994;142:343-363.
24. Nicotera P, Bellomo G, Orrenius S. Calcium mediated mechanism in chemically induced cell death. Ann Rev Pharmacol Toxicol 1992;32:449-470.
25. Bellomo G, Perotti M, Taddei F. Tumour necrosis factor a induces apoptosis in mammery adenocarcinoma cells by an increase in intracellular free calcium concentrations and DNA fragmentation. Cancer Res 1992;52:1342-1346.
26. Dowd DR, MacDonald PN, Kemm BS, Maussler MR, Miesfeld R. Evidence of early induction of calmodulin gene expression in lymphocytes undergoing glucocorticoid mediated apoptosis. J Biol Chem 1991;266:18423-18426.
27. Zhu W, Murtha PE, Toung CYF. Calpain inhibitor induced apoptosis in human prostate adenocarcinoma cells. Biochem Biophys Res Comm 1995;214:1130-1137.
28. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994;15:7-10.
29. Slater AFG, Stefan C, Nobel I, van del Dobbelsteen DJ, Orrenius S. Intracellular redox changes during apoptosis. Cell Death Differ 1996;3:57-62.
30. McGowan AJ, Ruiz-Ruiz MC, Gorman AM, Lopez Rivas A, Cotter TG. Reactive oxygen intermediates (ROI): Common mediator(s) of poly(ADP-ribose) polymerase (PARP) cleavage and apoptosis. FEBS Lett 1996;392:299-303.
31. Tores-Roca JF, Lecoeur H, Amatore C, Gougeon ML. The early intracellular production of a reactive oxygen intermediate mediates apoptosis in dexamethasone-treated thymocytes. Cell Death Differ 1995;2:309-319.
32. Nobel CSI, Kimland M, Lind B, Orrenius S, Slater AFG. Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper. J Biol Chem 1995;270:26202-26208.
33. Slater AFG, Stefan C, Nobel I, Maellaro E, Bustamante J, Kimland M, Orrenius S. Nitrone spin traps and a nitroxide anti-oxidant inhibit a common pathway of thymocyte apoptosis. Biochem J 1995;306:771-778.
34. Verhaegen S, McGowan AJ, Brophy AR, Fernandes RS, Cotter TG. Inhibition of apoptosis by antioxidants in the human HL-60 leukaemia cell line. Biochem Pharmacol 1995;50:1021-1029.
35. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994;77:817-827.
36. van Dobbelsteen DJ, Nobel CSI, Schlegel J, Citgreave IA, Orrenius S, Stater AFG. Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/Apo-1 antibody. J Biol Chem 1996;271:15420-15427.
37. Macho A, Hirsch T, Marzo I, Marchetti P, Dallaporta B, Susin SA, Zamzami N, Kroemer G. Glutathione depletion is an early and calcium elevation a late event in thymocyte apoptosis. J Immunol 1997;15:4612-4619.
38. Fernandes RS, Cotter TG. Apoptosis or necrosis: Intracellular levels of glutathione influence mode of cell death. Biochem Pharmacol 1994;48:675-681.
39. Grune T, Reinheckel T, Joshi M, Davies KJA. Proteolysis in cultured liver epithelial cells during oxidative stress. J Biol Chem 1995;270:2344-2351
40. Vaux P, Cory S, Adams JM. Bcl-2 gene promotes haemopoetic cell survival and cooperates with c-myc to immortalise pre-B cells. Nature 1988;335:440-442.
41. Oltvai ZN, Milliman CL, Korsmeyer S. Bcl-2 heterodimerises in vivo with a conserved homolog Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
42. Hacker G, Vaux DL. A sticky buisness. Curr Biol 1995; 5:622-624.
43. Reed JC. Double identity for proteins of the bcl-2 family. Nature 1997;387:773-776.
44. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong SL, Ng S-C, Fesik SW. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 1996;381:335-341.
45. Baffy G, Miyashita T, Wiliamson TR, Reed JC. Apoptosis induced by withdrawal of interleukin-3 from an IL-3 dependent hematopoetic cell line is associated with a repartitioning of intracellular calcium and is blocked by enforced bcl-2 oncoprotein production. J Biol Chem 1993;268: 6511-6519.
46. Lam M, Dubyak G, Chen L, Nunez G, Miesfeld RL, Distelhorst CW. Evidence that bcl-2 represses apoptosis by regulating endoplasmic recticulum associated calcium fluxes. Proc Natl Acad Sci USA 1994;91:6569-6573.
47. Ryan JJ, Prochownik E, Gottlieb CA, Apel IJ, Merino R, Nunez G, Clarke MF. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 1994;91:5878-5882.
48. Minn AJ, Velez P, Schendel SL, Liang H, Muchmore SW, Fesik SW, Fill M, Thompson CB. Bcl-XL forms an ion channel in sythetic lipid membranes. Nature 1997;385:353-357.
49. Schendel SL, Xie Ze, Montal MO, Matsuyama S, Montal S, Reed JC. Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci USA 1997;94:5113-5118.
50. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta converting enzyme. Cell 1993;75:641-652.
51. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171.
52. Kaufmann Sh, Desndyer S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly (ADP-ribose) polymerse: An early marker for chemotherapy induced apoptosis. Cancer Res 1993;53:3976-3985.
53. Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995;182: 1625-1634.
54. Sharp PA. Split genes and RNA splicing. Cell 1994;77: 805-815.
55. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A. Specific cleavage of the 70Kdal protein component of the small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994;269: 30757-30760.
56. Voekel-Johnson C, Entingh AJ, Wold WSM, Gooding LR, Laster SM. Activation of intracellular proteases is an early event in TNF-induced apoptosis. J Immunol 1995;154: 1707-1716.
57. Oberhammer FA, Hochegger K, Froschl G, Tietenbacher R, Parelka M. Chromatin condensation during apoptosis is accompanied by degradation of Lamin A+B, without enhanced activation of cdc-2 kinase. J Biol Chem 1994; 126:827-837.
58. Brancolini C, Benedetti M, Scheider C. Microfilament reorganisation during apoptosis: The role of Gas2, a possible substrate for ICE like proteases. EMBO J 1995;14: 5179-5190.
59. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997;89:175-184.
60. Tewari M, Dixit VM. Fas and tumor necrosis factor induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 1995;270:3255-3260.
61. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1beta converting enzyme, a mammalian homologue of the C. elegans cell death gene ced-3. Cell 1993;75:653-660.
62. Bump NJ, Hackett M, Hugunin M, Seshagiri S, Brady K, Chen P, Ferenz C, Franklin S, Ghayur T, Li P, Licari P, Mankovich J, Shi L, Greenberg - A, Miller LK, Wong WW. Inhibition of ICE family proteases by baculovirus anti-apoptotic protein P35. Science 1995;269:1885-1888.
63. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS-S, Flavell RA. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995;267:2000-2003.
64. Ko LJ, Prives C. p53: puzzle and paradigm. Genes & Dev 1996;10:1054-1072.
65. Maltzman W, Czyzyk L. U.V. irradiation stimulates levels of p53 cellular tumour antigen in nontransformed mouse cells. Mol Cell Biol 1984;4:1689-1694.
66. Sun X, Shimizu H, Yamamoto K. Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression. Mol Cell Biol 1995;15:4489-4496.
67. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig R W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311.
68. Lu X, Lane DP. Differential induction of transcriptionally active p53 following U.V. or ionising radiation: Defects in chromosome instability syndromes? Cell 1993;75:765-778.
69. Zhan Q, Carrier F, Forance AJ. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Biol 1993;13:4242-4250.
70. Graeber AJ, Osmanian C, Jack T, Housman DE, Koch CJ, Lowe SW, Graccia AJ. Hypoxia mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996;379:88-91.
71. Linke SP, Clarkin KC, DiLeonardo A, Tsou A, Wahl GM. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes & Dev 1996;10:934-947.
72. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. Waf-1, a potential mediator of p53 tumour supression. Cell 1993;57:817-825.
73. Morgan SE, Kastan MB. p53 and ATM: Cell cycle, cell death, and cancer. Adv Cancer Res 1997;71:1-25.
74. Yonish-Rouach E. The p53 tumour supressor gene: A mediator of G1 growth arrest and of apoptosis. Experientia 1996;52:1001-1007.
75. Lowe SW, Schmidt SM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation induced apotosis in mouse thymocytes. Nature 1993;362:847-849.
76. Miyashita T, Reed JC. Tumour supressor p53 is a direct transcription activator of the human bax gene. Cell 1995; 80:293-299.
77. Buckbinder L, Talbott R, Valesco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995;377: 646-649.
78. Miyashita T, Krajewski S Krajewski M, Wang HG, Lin HK, Hoffman B, Lieberman D, Reed JC. Tumour supressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-1805.
79. Guillouf C, Grana X, Selvakumaran M, De Luca XA, Giordano A, Hoffman B, Liebermann DA. Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: Blocking p53 induced apoptosis unmasks G1 arrest. Blood 1995;85:2691-2698.
80. Allday MJ, Inman GJ, Crawford DH, Farrell PJ. DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective. EMBO J 1995;14:4994-5005.
81. Canman CE, Gilmer TM, Coutts SB, Kastan MB. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes & Dev 1995;9:600-611.
82. Rowan S, Ludwig RL, Haupt YH, Bates S, Lu X, Oren M, Vousden KH. Specific loss of apoptotic but not cell cycle arrest function in a human tumour derived p53 mutant. EMBO J 1996;15:827-838.
83. Knudson C, Tunk K, Tourtellotte W, Brown G, Korsmeyer S. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995;270:96-99.
84. Owen-Schaub LB, Zhang W. Cusak JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang W-W, Kruzel E, et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 1995;15:3032-3040.
85. Goga A, Liu X, Hambuch TM, Senechal K, Major E, Berk AJ, Witte ON, Sawyers CL. p53-dependent growth supression by the c-Abl nuclear tyrosine kinase. Oncogene 1995;11:791-799.
86. Caelles C, Helmberg A, Karin M. p53-dependant apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994;370:220-223.
87. Haupt Y, Rowan S, Shaulian E, Vousden KH, Oren M. Induction of apoptosis in HeLa cells by transactivation deficient p53. Genes & Dev 1995;9:2170-2183.
88. Deng C, Zhang P, Harrper JW, Elledge SJ, Leder P. Mice lacking p21PCII/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995;82:675-684.
89. Trauth BC, Klas C, Peters AMJ, Matzku, Moler P, Falk W, Debatin KM, Krammer PH. Monoclonal antibody-mediated tumour regression by induction of apoptosis. Science 1989;245:301-305.
90. Yonehara S, Ishii A, Ynehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumour necrosis factor. J Exp Med 1989;169:1747-1756.
91. Mariani SM, Matiba B, Armanola EA, Krammer PH. The Apo-1/Fas(CD95) receptor is expressed in homozygous Mrl/lpr mice. Eur J Immunol 1994;24:3119-3123.
92. Watanabe-Fukunga R, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apotosis. Nature 1992;356:314-317.
93. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. Generalised lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 1994;76:969-976.
94. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-1192.
95. Itoh N, Nagata S. A novel protein domain required for apotosis. Mutational analysis of human Fas antigen. J Biol Chem 1993;268:10932-10937.
96. Hofmann K, Tschoppp J. The death domain motif in Fas (Apo-1) and TNF receptor is present in proteins involved in apoptosis and axonal guidance. FEBS Lett 1995;371:321-323.
97. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME. Cytotoxicity dependent Apo1(Fas/CD95)-associated proteins (CAP) form a death inducing signal complex (DISC) with the receptor. EMBO J 1995;14:5579-5588.
98. Hsu H, Shu H-B, Pan MP, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor-1 signaling complexes. Immunity 1996;4:387-396.
99. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, Dixit VM. FADD/MORT1 is a common mediator of CF95(Fas/Apo-1) and TNF receptor induced apoptosis. J Biol Chem 1996;271:4961-4965.
100. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer J-L, Schroterm M, Scaffidi C, Krammer PH, Peter ME, Tschopp J. Viral FLICE-inhibitory proteins (FLIPS) prevent apoptosis induced by death receptors. Nature 1997;386:517-521.
101. Bertin J, Armstrong RC, sabine O, Martin DA, Wang Y, Banks S, Wang G-H, Senekevich TG, Alnemri ES, Moss B, Lenardo MJ, Tomaselli KJ, Cohen JI. Death effector domain-containing herpesvirus and poxvirus proteins inhibit Fas and TNKR-1 induced apoptosis. Proc Natl Acad Sci USA 1997;94:1172-1176.
102. Nagata S. Apoptosis by death factor. Cell 1997;88:355-365.
103. Irmler M, Thome M, Hahne M, Scheider P, Hofman K, Steiner V, Bodemer J-L, Schoter M, Burns K, Mattman C, Rimoldi D, French LE, Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 1997;388:190-195.
104. Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995;375:78-81.
105. Duan H, Chinnaiyan AM, Hudson PL, Wing JP, He W, Dixit VM. ICE-Lap3, a novel mammalian homologue of the C. elegans death protein CED-3, is activated during Fas and tumour necrosis factor induced apoptosis. J Biol Chem 1996;271:35013-35035.
106. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death inducing signaling complex. Cell 1996;85:817-827.
107. Srinivasula SM, Fernandes-Alnemti T, Znagrilli J, Robertson N, Armstrong RC, Wanc L, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES. The CED3/interleukin-1 b converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2a are substrates for the apoptotic mediator CPP32. J Biol Chem 1996;271:27099-27106.
108. Vincenz C, Dixit VM. Fas-associated death domain protein interleukin-1b-converting enzyme 2 (FLICE2), an ICE/ Ced-3 homologue is proximally involved in CD95-and p55-mediated death signalling. Biol Chem 1997;272: 6578-6583.
109. Skowronski EW, Kolesnick RN, Green DR. Fas mediated apoptosis and sphingomyelinase signal transduction: The role of ceramide as a second messenger for apoptosis. Cell Death Differ 1996;3:171-176.
110. Hockenbery DM, Nuniz G, Milliman C Scheiber RD, Korsmeyer SJ. -Bel-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348: 334-336.
111. Newmeyer DD, Farschan DM, Reed JC. Cell free apoptosis in Xenopus egg extracts: Inhibition by bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 1994;79:353-364.
112. Kroemer G. Mitochondrial implication in apoptosis. Towards an endosymbiont hypothesis of apoptosis evolution. Cell Death Differ 1997;4:443-456.
113. Susin SA, Zamzami N, Custedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 1996;184:1331-1341.
114. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome-c from motochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997;275: 1132-1136.
115. Liu K, Kim NC, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell free extracts: Requirement for dATP and cytochrome c. Cell 1996;86:147-157.
116. Yang J, Liu K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP, Wang X. Prevention of apoptosis by Bcl-2: Release of cytochrome-c from mitochondria blocked. Science 1991; 275:1129-1132.
117. Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode C. elegans. Cell 1986;75:641-652.
118. Yuan JY, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta converting enzyme. Cell 1993;75:641-652.
119. Vaux DL, Weissman IL, Kim SK. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 1992;258:1955-1957.
120. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED 4, participates in cytochrome-c dependent activation of caspase-3. Cell 1997;90:405-413.
121. Chinnaiyan AM, O'Rourke K, Lane BR, Dixit VM. Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science 1997;275:1122-1126.